This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Utrecht University. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: Herman F. Egberink - Pioneering Innovations in Feline Coronaviruses
Introduction
Herman F. Egberink, a dedicated inventor based in Utrecht, Netherlands, has made significant contributions to the field of veterinary medicine through his innovative research. With a focus on feline coronaviruses, his work provides crucial insights into diagnosing and understanding feline infectious peritonitis virus (FIPV) and feline enteric coronavirus (FECV).
Latest Patents
Herman F. Egberink holds one patent titled "Means and methods for distinguishing FECV and FIPV." This invention offers valuable methods and means for differentiating between FECV and FIPV, which is essential for accurate diagnosis and treatment. The patent further includes primers and probes for detecting FIPV-specific nucleic acid sequences that encode a spike protein, alongside antibodies for identifying FIPV. Additionally, it details an immunogenic composition aimed at eliciting an immune response against feline coronaviruses, specifically targeting FIPV.
Career Highlights
Egberink currently works with Universiteit Utrecht Holding B.V., where his research intersects the fields of virology and veterinary science. His contributions not only enhance our understanding of feline coronaviruses but also assist in developing effective diagnostics and therapeutic strategies for these diseases.
Collaborations
Throughout his career, Herman F. Egberink has collaborated with distinguished colleagues, including Petrus Josephus Marie Rottier and Hui-wen Chang. These collaborations have helped to advance the research and development of innovative methods for the detection and treatment of feline coronavirus infections.
Conclusion
Herman F. Egberink's innovative work in the area of feline coronaviruses showcases his commitment to advancing veterinary science. His patent for distinguishing between FECV and FIPV signifies a remarkable step forward in understanding and addressing feline infectious diseases. Through his research and collaborations, he continues to make a lasting impact in the world of veterinary medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile